These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38987797)

  • 1. The construction of machine learning-based predictive models for high-quality embryo formation in poor ovarian response patients with progestin-primed ovarian stimulation.
    Xiao YH; Hu YL; Lv XY; Huang LJ; Geng LH; Liao P; Ding YB; Niu CC
    Reprod Biol Endocrinol; 2024 Jul; 22(1):78. PubMed ID: 38987797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles.
    Vidal MDM; Martínez F; Rodríguez I; Polyzos NP
    Hum Reprod; 2024 May; 39(5):1098-1104. PubMed ID: 38498835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF/ICSI compared to a GnRH antagonist protocol: A retrospective study.
    Huang P; Tang M; Qin A
    J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):99-102. PubMed ID: 30321608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin-primed ovarian stimulation protocol with or without letrozole for patients with normal ovarian reserve: a retrospective cohort study.
    Jiang X; Jiang S; Diao H; Deng K; Zhang C
    J Clin Pharm Ther; 2022 Apr; 47(4):469-476. PubMed ID: 34796515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response.
    Zhang J; Du M; Li Z; Liu W; Ren B; Zhang Y; Guan Y
    Front Endocrinol (Lausanne); 2021; 12():708704. PubMed ID: 34630325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letrozole cotreatment progestin-primed ovarian stimulation in women undergoing controlled ovarian stimulation for in vitro fertilization.
    Wang X; Zhang Y; Diao H; Jiang S; Zhang C
    J Obstet Gynaecol Res; 2024 May; 50(5):890-898. PubMed ID: 38403851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of IVF/ICSI-FET Outcomes in Women With Advanced Endometriosis: Influence on Ovarian Response and Oocyte Competence.
    Li A; Zhang J; Kuang Y; Yu C
    Front Endocrinol (Lausanne); 2020; 11():427. PubMed ID: 32765424
    [No Abstract]   [Full Text] [Related]  

  • 9. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
    Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
    PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
    Tu X; You B; Jing M; Lin C; Zhang R
    Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial to compare the live birth rate of the first frozen embryo transfer following the progestin-primed ovarian stimulation protocol vs. the antagonist protocol in women with an anticipated high ovarian response.
    Chen ZQ; Ai A; Zhang Y; Li H; Wang JY; Wang L; Ng EHY
    Fertil Steril; 2024 Jun; 121(6):937-945. PubMed ID: 38272383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF/ ICSI Cycle: A Self-controlled Study.
    Chen YM; Qi QR; Xie QZ; Yang YF; Xia Y; Zhou XD
    Curr Med Sci; 2018 Jun; 38(3):513-518. PubMed ID: 30074220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different progestin-primed ovarian stimulation protocols in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: an analysis of 1188 cycles.
    Guo YC; Chen PY; Li TT; Jia L; Sun P; Zhu WS; Deng CC; Fang C; Liang XY
    Arch Gynecol Obstet; 2019 Apr; 299(4):1201-1212. PubMed ID: 30852654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.
    Du M; Zhang J; Li Z; Liu X; Li J; Liu W; Guan Y
    Front Endocrinol (Lausanne); 2021; 12():705264. PubMed ID: 34589055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
    Bülow NS; Warzecha AK; Nielsen MV; Andersen CY; Holt MD; Petersen MR; Sopa N; Zedeler A; Englund AL; Pinborg A; Grøndahl ML; Skouby SO; Macklon NS
    Hum Reprod; 2023 Nov; 38(11):2154-2165. PubMed ID: 37699851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovulation induction with high progesterone levels may be more suitable for elderly patients with low ovarian response.
    Mu Z; Sa Y; Sun Z; Yi Y
    J Gynecol Obstet Hum Reprod; 2021 Feb; 50(2):101661. PubMed ID: 31809957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.
    Zhou R; Dong M; Huang L; Wang S; Fan L; Liang X; Zhang X; Liu F
    Front Endocrinol (Lausanne); 2023; 14():1117513. PubMed ID: 37143731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestin-primed ovarian stimulation improves the outcomes of IVF/ICSI cycles in infertile women with diminished ovarian reserve.
    Yu CM; Dai XL; Wang YF; Gao TT; Cao F; Xia XY; Chen L
    J Chin Med Assoc; 2019 Nov; 82(11):845-848. PubMed ID: 31453864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF.
    Pai AH; Sung YJ; Li CJ; Lin CY; Chang CL
    Reprod Biol Endocrinol; 2023 Aug; 21(1):72. PubMed ID: 37550681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.